| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |